Methods of treating Crohn's disease with anti-IL23 specific antibody
US12138295B2 · kind B2 · utility
0Cited by
136References
15Claims
0Family size
Inventors
Key dates
| Filing date | Mar 25, 2021 |
| Grant date | Nov 12, 2024 |
| Priority date | — |
| Expiry date | Oct 4, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequence subcutaneous doses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.